Lichen Sclerosus and the Menopause: What Every Woman Should Know

Written by Dr Shirin Lakhani MBBS MRCGP DRCOG — GMC No. 4634863 | CQC-Registered Practitioner | Lead Clinician, Elite Aesthetics, Near London

Lichen Sclerosus and the Menopause: What Every Woman Should Know

Lichen sclerosus affects women of all ages, but its peak incidence falls squarely around and after the menopause. The result is that tens of thousands of women in the UK are navigating two significant hormonal and skin conditions at exactly the same time — often unsure whether their symptoms are caused by one, the other, or both.

As a GP and aesthetic doctor with a specialist focus on women’s intimate health, I see this overlap every week at Elite Aesthetics in Near London. Women arrive having been told for months, sometimes years, that their discomfort is “just the menopause.” In many cases, lichen sclerosus has been quietly progressing beneath the surface, undiagnosed and untreated.

This article explains the relationship between lichen sclerosus and the menopause in plain terms: why the two so often occur together, how to tell them apart, and which evidence-based treatments — including newer regenerative options — can make a real difference to your quality of life.

Why Lichen Sclerosus Is So Common Around the Menopause

Lichen sclerosus (LS) is a chronic inflammatory skin condition that most commonly affects the vulva, with a secondary peak in men affecting the foreskin (where it is called balanitis xerotica obliterans). In women, diagnosis peaks in two distinct hormonal windows: prepubescent girls and post-menopausal women — both periods of very low circulating oestrogen.

The exact cause of lichen sclerosus remains under investigation, but the current medical consensus points to an autoimmune mechanism. The immune system misidentifies a protein in the basement membrane of the vulval skin and mounts an inflammatory attack against it. This produces the characteristic white, thinned, and sometimes scarred tissue seen in established LS.

Why, then, does it cluster around the menopause? Several factors are likely at play:

• Declining oestrogen reduces vulval tissue resilience. Oestrogen receptors are distributed throughout the vulva, vagina, and surrounding tissues. As oestrogen levels fall during perimenopause and menopause, those tissues become thinner, drier, and more vulnerable to inflammatory processes.
• Immune dysregulation peaks post-menopause. Almost a third of women with vulval lichen sclerosus have at least one other autoimmune condition — most commonly thyroid disease, alopecia areata, or vitiligo — compared with around 10% of women without LS. The hormonal shifts of menopause may tip the immune balance in susceptible women.
• Delayed diagnosis means many cases are only caught at this stage. LS can begin earlier in life and remain mild or intermittent. Menopause may cause a genuine flare, or simply push symptoms past the threshold at which a woman seeks help.

Importantly, while low oestrogen creates conditions in which LS can worsen, the condition is not caused by oestrogen deficiency alone — and treating LS with oestrogen cream alone will not resolve it. This distinction matters enormously for getting the right treatment.

Lichen Sclerosus vs the Menopause: How to Tell Them Apart

The symptoms of lichen sclerosus and genitourinary syndrome of menopause (GSM) overlap significantly — which is precisely why LS is so frequently missed or misdiagnosed in menopausal women. Both conditions can cause vulval dryness, burning, soreness, and pain during intercourse. But there are key differences.

The two conditions frequently co-exist. A 2023 study published in Sexual Medicine demonstrated that treating co-existent GSM in women with lichen sclerosus significantly improved overall symptom burden — underscoring the importance of a thorough assessment that considers both diagnoses simultaneously.

At Elite Aesthetics in Near London — Dr Shirin takes a full hormonal and skin history at every lichen sclerosus consultation. If you are perimenopausal or post-menopausal, both conditions are assessed and a coordinated treatment plan is created.

Does HRT Help Lichen Sclerosus?

Hormone replacement therapy (HRT) is a legitimate and effective treatment for the genitourinary symptoms of menopause — vaginal dryness, burning, discomfort during sex, and recurrent urinary symptoms. But its role in lichen sclerosus is more nuanced.

HRT — whether systemic (patches, gel, tablets) or local vaginal oestrogen (pessaries, cream, gel, ring) — does not treat lichen sclerosus directly. Clinical observation does suggest, however, that women on HRT and/or vaginal hormones generally experience better background vulval tissue quality, which may reduce the frequency and severity of LS flares.

The current clinical picture, supported by data from the Newson Health menopause clinic and practitioners including Dr Louise Newson, is that:

• Vaginal oestrogen is safe for most post-menopausal women, including those who cannot take systemic HRT.
• It should be used alongside topical corticosteroid treatment for LS, not instead of it.
• Women with LS who are post-menopausal should be assessed for co-existent GSM and offered appropriate hormonal support where clinically indicated.

One important caveat: women taking aromatase inhibitors for breast cancer treatment (which suppress oestrogen very aggressively) often experience severe LS flares. If you are in this situation, specialist input from a doctor with expertise in both oncology and intimate skin health is essential.

How Lichen Sclerosus Is Treated in Menopausal Women

The first-line treatment for lichen sclerosus remains ultra-potent topical corticosteroids — most commonly clobetasol propionate 0.05%. Used correctly on a reducing regimen, this treatment controls inflammation, reverses early scarring in some cases, and significantly reduces the risk of vulval cancer in untreated disease. It does not cure LS, which is a lifelong condition requiring ongoing management.

For women who have been through the menopause, several additional factors shape the treatment plan at Elite Aesthetics in Near London:

Topical Steroids

Clobetasol propionate remains the gold standard. The correct regimen — daily for one month, alternate days for one month, twice weekly for one month, then maintenance — is critical. Many women come to us having been prescribed the right cream but given no guidance on the regimen, resulting in inadequate treatment.

Vaginal Oestrogen

For post-menopausal women with co-existent GSM, local vaginal oestrogen (Vagifem, Ovestin, Blissel, or similar) is used alongside corticosteroid cream to support overall vulval and vaginal tissue health. This is not treating the LS itself but improves the tissue environment in which treatment occurs.

The O-Shot (PRP)

The O-Shot for lichen sclerosus uses platelet-rich plasma (PRP) derived from your own blood. Concentrated growth factors are injected into the affected vulval tissue, stimulating stem cell activity, tissue regeneration, and collagen remodelling. A growing body of case series and pilot study data supports PRP as an effective adjunct treatment for LS, particularly in women who have achieved initial disease control with steroids but continue to experience symptoms.

A 2025 randomised controlled trial published in PMC found that laser therapy (Nd:YAG/Er:YAG) produced improvements in LS comparable to topical steroids. Notably, post-menopausal women in that trial were more likely to use local oestrogen (74% versus 16% in premenopausal women) and experienced a lower subjective disease burden — suggesting that combined hormonal and regenerative approaches may be particularly beneficial in this group.

Morpheus8V

Morpheus8V is a fractional radiofrequency microneedling device designed specifically for vaginal and vulval tissue. It stimulates collagen production in the superficial and deeper tissue layers, improving skin texture, elasticity, and moisture — all of which are compromised in both LS and post-menopausal GSM. At Elite Aesthetics, Morpheus8V is used as part of a multimodal treatment plan for women with LS, particularly those for whom steroids have controlled active inflammation but residual tissue damage remains.

Laser Therapy

Fractional CO2 and Nd:YAG laser treatments are increasingly supported by evidence for LS. Laser energy promotes tissue remodelling in the dermis, addressing the fibrotic changes that characterise established lichen sclerosus. Research published in 2026 in PMC also confirmed high effective rates for combined therapies when compared with glucocorticoids alone.

What to Expect at an Elite Aesthetics Lichen Sclerosus Consultation

Many women who come to Elite Aesthetics in Near London for lichen sclerosus assessment have previously received only a brief examination and a prescription for steroid cream. A thorough consultation at our clinic looks at the whole picture.

Dr Shirin will take a detailed history covering your LS symptoms, any menopausal symptoms, your hormonal status (including current HRT use), other autoimmune conditions, and any previous treatments and their response. An examination assesses the current stage and distribution of LS, the degree of any structural change, and whether co-existent GSM is present.

From this, a personalised treatment plan is created. This may include one or more of the options detailed above, with clear guidance on how and when to use each. Follow-up is scheduled based on your individual response to treatment.

Women travelling from London, Essex, and Surrey make up a significant proportion of our lichen sclerosus patients. Elite Aesthetics is consistently regarded as one of the UK’s leading doctor-led lichen sclerosus clinics — with Dr Shirin’s specialist training, GMC registration (No. 4634863), and CQC oversight providing the clinical governance that this complex condition demands.

The Emotional Impact of Lichen Sclerosus During and After the Menopause

The convergence of lichen sclerosus and the menopause is not merely a physical challenge. For many women, this period involves significant psychological distress — compounded by the fact that intimate health conditions remain poorly discussed and often dismissed by healthcare providers.

Symptoms including chronic itch, painful sex, altered vulval appearance, and the anxiety of a lifelong diagnosis can seriously affect self-esteem, relationships, and mental wellbeing. Research published in 2026 has strengthened the established link between lichen sclerosus and depression, with studies identifying LS as an independent risk factor for depressive symptoms — distinct from the mood changes associated with menopause itself.

At our clinic in Near London — we understand that treating lichen sclerosus means addressing the full impact of the condition, not just the skin findings. Patients are encouraged to discuss the emotional dimensions of living with LS, and signposting to counselling or peer support (including the Lichen Sclerosus Support Network) is offered where appropriate.

Long-Term Monitoring: Why Regular Review Matters

Lichen sclerosus carries a small but real increased risk of vulval squamous cell carcinoma (SCC). Estimates vary, but the figure most consistently cited in the literature is approximately 4–6% over a lifetime. This risk is substantially reduced — but not eliminated — by consistent, appropriate treatment.

Annual review by a clinician experienced in vulval conditions is recommended for all women with an established LS diagnosis. At each review, Dr Shirin assesses for:

• Response to ongoing treatment
• Disease activity and any new symptomatic areas
• Structural changes, including any worsening of scarring or fusion
• Any suspicious lesions requiring biopsy or urgent referral
• Side effects of long-term topical steroid use (typically atrophy or secondary infection)

Women in the post-menopausal years should also have any new skin changes evaluated promptly rather than attributed to menopause without examination. A patch that is persistently white, thickened, ulcerated, or fails to respond to treatment should always be assessed by an experienced clinician.

You can find more information about how lichen sclerosus is managed over the long term at our lichen sclerosus treatment page. For more on the broader treatment landscape, see our guide on the best lichen sclerosus treatment options.

Frequently Asked Questions: Lichen Sclerosus and the Menopause